About Christopher Jewell
Form D filings for Nodal Therapeutics in 2024 list Christopher Jewell as chief executive officer and director.
Christopher Jewell first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Jewell in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher Jewell works with at each company, as listed on that company's latest Form D.
Nodal Therapeutics, Inc. · Form D/A, Oct 29, 2024
JB
Jonathan Bromberg
Executive officer